<DOC>
	<DOCNO>NCT01253850</DOCNO>
	<brief_summary>HIV increase among adolescent young adult US . Antiretroviral medication , take correctly ( â‰¥90 % prescribed dose take ) , vastly improve life expectancy . However , adherence among HIV-infected young people suboptimal , intervention available help adolescent adhere treatment . The first phase study intervention development phase , include conduct interview 40 HIV-infected youth input adaptation approach . The information obtain qualitative interview use adapt Life-Steps intervention ( design group HIV-infected adult ) responsive need HIV-infected adolescent , acceptability topic content , feasibility intervention delivery test open pilot trial .</brief_summary>
	<brief_title>Improving Antiretroviral Medication Adherence Among HIV-infected Youth : Phase I</brief_title>
	<detailed_description>This phase protocol focus set infrastructure necessary conducting study , include hire training activity study staff . This time spend conduct interview use data inform development intervention protocol adaptation Life-Steps intervention material , include study assessment instrument , HIV-infected youth . The interview one-time event last 1.5-2 hour . It two component : quantitative assessment qualitative discussion . After participant complete informed consent assent ( age 18 ) process , research staff administer brief quantitative assessment ask question related demographic , medication adherence , sexual risk , substance use , psychosocial condition . The second part interview open discussion . The interview conduct trained member research staff . The interview inform pre-determined qualitative topic guide .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>Phase I Age 13 24 year HIVinfected aware HIVinfection status Currently take antiretroviral therapy , prescribed antiretroviral therapy past 6 month , medical provider recommend antiretroviral medication within last 6 month Willing able provide inform consent assent ( age 18 ) Not willing able provide inform consent assent ( age 18 ) Is deal severe mental illness require immediate treatment ( e.g . active psychotic episode ) mental illness would limit participant 's ability engage study protocol ( e.g . dementia ) Has severe cognitive limitation would limit participant 's ability comprehend inform consent assent . Phase II Age 1324 year HIVinfected aware HIVinfection status Currently take antiretroviral therapy Selfreported difficulty adhere HIV medication past 3 month Selfidentify heterosexual LGB Willing able provide inform consent/consent parent/guardian age 18 Not willing able provide inform consent assent ( age 18 ) Is deal severe mental illness require immediate treatment ( e.g . active psychotic episode ) mental illness would limit participant 's ability engage study protocol ( e.g . dementia ) Has severe cognitive limitation would limit participant 's ability comprehend inform consent assent .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>24 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>hiv</keyword>
	<keyword>antiretroviral</keyword>
	<keyword>adherence</keyword>
	<keyword>adolescent</keyword>
</DOC>